Search
for
Sort by
Research 961–990 of 1000+
- CD44/TRPV1 dual-targeted nanocarrier enables drug retention and multidimensional therapy for inflammatory skin diseases
- PROTACs in cancer therapy: targeted degradation of GPX4, PARP and epigenetic regulators
- PCA: A tFNA-based targeted nucleic acid nanocomposite hydrogel for the treatment of androgenetic alopecia through the promotion of angiogenesis and hair follicle stem cell proliferation
- Hair follicle-targeted baicalin nanocrystal delivery using microneedles for long-acting treatment of androgenetic alopecia
- Niosomal Nanoformulations for Targeted Follicular Drug Delivery in Alopecia: An Integrative Review of Pathophysiology, Therapies, and Nanotechnology-Based Approaches
- From Misdiagnosis to Targeted Therapy: A Case Report of Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum
- 0054 Treg-targeted therapies restrain disease in a murine model of alopecia areata
- 525 Aptamer-Based Targeted Therapy for wound healing and hair growth promotion
- 130 Dermal IgA deposition targeted against Transglutaminase 3 in Dermatitis herpetiformis risk groups
- Microsponges-mediated targeted topical delivery of rosemary oil for hair growth promotion: optimization and in-vivo studies
- Hair Follicle-Targeted Delivery of Azelaic Acid Micro/Nanocrystals Promote the Treatment of Acne Vulgaris
- Research Progress on Targeted Regulation of Hair Follicle Stem Cell Function in the Treatment of Androgenetic Alopecia
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Management of the adverse effects of targeted therapy for cancer
- Design of a targeted drug delivery system to reshape the perifollicular microenvironment in androgenetic alopecia
- 032 A multicomponent skin-targeted COVID-19 vaccine elicits robust humoral and cellular immune responses
- Folate-cyclodextrin Conjugate for Targeted Chemotherapy
- Faculty Opinions recommendation of Targeted skin overexpression of the mineralocorticoid receptor in mice causes epidermal atrophy, premature skin barrier formation, eye abnormalities, and alopecia.
- Colon Cancer Stem Cells: Promise of Targeted Therapy
- Defective trophoblast function in mice with a targeted mutation of Ets2
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted <sup>99m</sup>Tc-Radioimaging Agents
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- Self-assembled polymeric nanocarriers for the targeted delivery of retinoic acid to the hair follicle
- Cellular senescence in skin‐related research: Targeted signaling pathways and naturally occurring therapeutic agents
- Uterus Hyperplasia and Increased Carcinogen-Induced Tumorigenesis in Mice Carrying a Targeted Mutation of the Chk2 Phosphorylation Site in Brca1
- Microneedles mediated bioinspired lipid nanocarriers for targeted treatment of alopecia
- Non-Rash Skin Toxicities Associated with Novel Targeted Therapies
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Degradable co-delivery nanoplatforms for inflammation-targeted therapy against atherosclerosis